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andida species in the lower respiratory tract of healthy
ndividuals
.J. Salzer1,∗, R.B. Raggam2, I. Zollner-Schwetz1, M.
oenigl 1, T. Valentin1, R. Krause1
Medical University of Graz, Graz, Austria
University Hospital Graz, Graz, Austria
Background: Candida species (spp.) are frequently iso-
ated from respiratory tract secretions such as endotracheal
spirates (EA) in patients with pulmonary inﬁltrates. Since
he prevalence of Candida spp. in the lower respiratory
ract is unknown in healthy individuals the pathogenetic
elevance of Candida spp. in the lower respiratory tract is
ifﬁcult to assess.
Methods: A total of 71 healthy individuals without clini-
al, laboratory or radiological evidence of respiratory tract
nfections (temperature >38 ◦C, elevated CRP >8mg/dl,
eukocytosis >11400, elevated neutrophiles) or any other
ung diseases (e.g. COPD, asthma bronchiale, sarcoidosis,
nterstitial lung disease, malignant diseases of the lung)
ndergoing general anaesthesia due to elective surgery
ere enrolled. Exclusion criteria included antifungal ther-
py within 8 weeks and antimicrobial therapy within 4 weeks
rior to study inclusion (with the exception of antimicrobial
urgical prophylaxis), immunosuppressive therapy, active
aematooncological diseases and HIV positivity. The pres-
nce of Candida spp. in the lower respiratory tract was
nvestigated in EA samples cultivated on Candida CHROMa-
ar. The Candida colonies were differentiated as C. albicans,
. glabrata, C. krusei, C. tropicalis or others according
o the color of colonies and by API Aux test. For bacte-
ial growth EA samples were further cultivated on selective
gars. Bacterial cultures are counted and identiﬁed by rou-
ine microbiological procedures. In addition, oral swabs
ere obtained and cultured on Candida CHROMagar.
Results: A total of 88 microorganisms were isolated from
1 of the 71 EA samples containing 1 yeast (C. krusei),
2 gram-positive and 25 gram-negative bacterial species
ncluding the indigenous oral ﬂora. In 30 EA samples nei-
her bacteria nor fungi were cultured. A total of 24 Candida
pp. were isolated from 21 of the 71 oral swabs containing
8C. albicans, 2C. glabrata and 1C. krusei isolates. In addi-
ion, C. krusei isolated from both EA sample and oral cavity
as originated within the same patient.
Conclusion: The colonization of the lower respiratoryract with Candida spp. in healthy individuals seems to be
ncommon, despite a relative frequent Candida spp. colo-
ization of the oral cavity.
oi:10.1016/j.ijid.2010.02.1742
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nﬂuence of gender, age, previous hospitalization and
ospital stay on Candida-colonization of patients in a non-
urgical ICU
. Gloeckner1,∗, P. Abel2
BDH-Klinik Greifswald, Greifswald, Germany
University of Greifswald, Greifswald, Germany
Background: The incidence of systemic fungal infections
s increasing and their mortality remains high despite all
dvances in therapy. Accurate diagnostic measures are still
ifﬁcult to obtain and evaluate in order to determine the
eed for antifungal treatment. Moreover, Candida species
iffer substantially in their antimycotic susceptibility. Thus
nowledge of species to be expected is crucial for not miss-
ng the diagnosis and making the right decision how to treat.
Methods: In a prospective study over 30 month we anal-
sed samples from 411 patients (160 women and 251 men,
ean age 63.6 years, mean APACHE-II-Score 20.8) admit-
ed to our ICU. Swabs from nostril, throat and anus and
pecimens of tracheal secretions and urine were taken and
ultured on CHROM- or CandID- Agar at 36 ◦C. The hospital-
zation history of the patients was investigated.
Results: Positive results were found in 43% of all
868 investigated samples. Concerning the distribution of
pecies, we found Candida albicans in 69%, Candida glabrata
n 35% and Candida tropicalis in 8% of all positive specimens.
he colonization index was higher in women than in men
mean 0.47 vs. 0.39, p < 0.01) with no signiﬁcant inﬂuence
f age. This difference was due to a higher rate of colo-
ization of anus and urine in women (both p < 0.001). The
pecies distribution showed no difference between sexes,
ut the rate of nonalbicans species rises signiﬁcantly with
ge (in females p < 0.05, in males p < 0.01). A hospital stay
onger than 7 days before admission to the ICU was linked
ith a higher rate of colonization (52% vs. 38%) but not with
signiﬁcant change in species distribution. Patients who had
een hospitalized within two years before the current hospi-
al admission, showed a higher rate of colonization (42% vs.
6%) and a higher proportion of non-albicans species (48%
s. 34%).
Conclusion: 1. Women are more frequently colonized
ith yeasts than men, particularly in urine and anal swabs.
. With advancing age, the proportion of non-albicans
pecies detected is increasing. 3. A longer duration of hos-
ital stay is associated with a higher colonization rate. 4.
epeated hospitalizations are linked with a higher rate of
on-albicans species.
oi:10.1016/j.ijid.2010.02.1743
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ixed fungal colonization in non-surgical intensive care
atients
. Gloeckner1,∗, P. Abel2, K. Zimmermann2BDH-Klinik Greifswald, Greifswald, Germany
University of Greifswald, Greifswald, Germany
Background: Knowledge of risk factors is important for
roperly applying and evaluating diagnostic tests to derive
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therapeutic conclusions. Colonization with fungi has been
identiﬁed as an independent risk factor for invasive myco-
sis. In addition to colonization with a single species, the
combination of different fungal species may be of interest.
Methods: In a prospective study we analyzed samples
taken from 411 patients after admission to our ICU. Swabs
from nostril, throat and anus and specimens of tracheal
secretions and urine were taken and cultured on CHROM-
Agar.
Results: Positive results were found in 798 (42.7%) of
all 1868 samples. Of these, 618 were positive for a single
species, 158 for two species, and 22 for three species. Con-
cerning distribution of species, we found Candida albicans
in 69.3%, Candida glabrata in 34.8% and Candida tropi-
calis in 8.1% of all positive specimens. In 90 cases, cultures
grew Candida albicans together with Candida glabrata, in 23
cases, Candida albicans together with Candida tropicalis, in
12 cases, Candida albicans together with Candida glabrata
and Candida tropicalis. Most frequently, a mixed coloniza-
tion was detected from throat swabs (74 mixed, out of 281
positive cultures, 26.3%), followed by tracheal secretions
(35 mixed, out of 153 positive cultures, 22.9%) and anal
swabs (48 mixed, out of 235 positive cultures, 20.4%). In con-
trast, a mixed colonization was signiﬁcantly less frequent in
nasal swabs (18 mixed, out of 136 positive cultures, 13.2%)
and in urine (5 mixed, out of 56 positive cultures, 8.9%).
Conclusion: A large proportion of samples showed growth
of yeasts. Out of culturally positive, in 22.6% were found
more than one species. Colonization with more than one
species was found to be signiﬁcantly more frequent in
throat, trachea and anus compared to nose and urine.
doi:10.1016/j.ijid.2010.02.1744
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Recent trends of Candida epidemiology in cancer and non-
cancer patients
M. Karthaus1,∗, R. Biedenkopf1, M. Hentrich2, X. Schiel 2, I.
Schuth3, G. Schwarzkopf-Steinhauser4
1 Klinikum Neuperlach/Tumorzentrum München Süd,
Munich, Germany
2 Klinikum Harlaching, Munich, Germany
3 KKS&C, Coblenz, Germany
4 Klinikum München, Munich, Germany
Background: In recent years a shift towards candida non
albicans has been reported from candidemia trials. A species
shift in candidemia is important, since newer guidelines
favor upfront echinocandins containing an economic bur-
den. This has to be balanced with medical needs. Trends
of epidemiology outside of controlledl trials are therefore
of particular interest.
We analyzed all candida isolates from ﬁve Munich teach-
ing hospitals (3500 beds). The objective was to compare all
candida isolates and all candidemia eps in 2008 and 09 with
the previous 2ys (data in brackets).
Methods: Between 01/08 and 10/09 a total of 15258 can-
dida isolates were detected. No routine azole prophylaxis
was given beside high risk cancer pts.There was no hint for
a seasonal cluster during the study periods.
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Results: While 64,20% (64.9%) were C. albicans, 7,5%
7.8%) were C. glabrata ahead of C. tropicalis with 4,7
4.6%), while in 1,74% C. krusei was detected. 384 isolates
ere obtained from two hemato-oncology units with C. albi-
ans 52, 3% (80.5%) ahead of C. glabrata 8,1% (7.8%), C.
ropicalis 5,4% (4.7%) and C. krusei (1.9%). A total of 148
solates were detected from blood cultures. C. albicans was
ound to be less common in candidemia 57,5% (58.9%), but
ominated far ahead of C. glabrata 17,1% (20.9%), C. trop-
calis 6,8% (7.0%), C. parapsilosis 4,8% (5.4%) and C. krusei
,7% (3.1%). 28.6% of candidemia eps was by C glabrata in
ancer pts in 2008 an 09.
Conclusion: Although a shift towards C. non albicans has
een described elsewhere, our study indicated C. albicans
emains the leading species. No further shift to C. glabrata
nd C. tropicalis has been observed within the last 4 years.
f candida is found, C. glabrata is detected about 2.3-fold
ore often and accounts for 17% of candidemia eps, with
n even 3.8-fold higher risk in cancer pts. Echinocandins,
ewer azoles and lipid AmB therefore seem to be justiﬁed
or upfront candidemia Rx, in particular cancer and those
ts with an unstable clinical condition.
oi:10.1016/j.ijid.2010.02.1745
0.005
nti-Saccharomyces cerevisiae (ASCA) antibody levels in
subgroup of patients with ulcerative colitis, Crohn’s dis-
ase, GI Behcet, and GI tuberculosis: Correlations with
isease duration, activity, and extension
. Aslan1,∗, B. Kocazeybek1, A. Celik2, Y. Erzin3, I.
atemi2, G. Hatemi2, H. Yazici 2
Istanbul University Cerrahpasa Faculty of Medicine,
urkey, Turkey
Istanbul University Cerrahpasa Faculty of Medicine, Istan-
ul, Turkey
Yeditepe University Medical Faculty, Istanbul, Turkey
Background: Clinical utility of serological markers in
nﬂammatory bowel disease (IBD) diagnosis and differen-
iating is controversial. Recently ASCA has been found to
ave some correlation with the complication and recurrent
urgery rate Our aim was to seek for correlations between
SCA levels and disease duration, extension, activity, CRP
evels, and use of immmunosupressive therapy
Methods: A total of 41 consecutive patients (16 UC,
0CD, 3 GI BD, and 2 GI Tb; 34 women, 7 male) were ana-
yzed regarding ASCA IgG levels with anti-ASCA IgG ELISA kit
Euroimmune, Lübeck, Germany), the cut-off value being
5 U/ml. Disease activity was assessed using SEO for UC and
DAI for CD, GI BD, and GI Tb patients, respectively. Addi-
ionally, a simpliﬁed endoscopic extension score was used
y dividing the colon into six equal units and accepting ileal
nvolvement as an additional unit in an ordinal manner. SPSS
5 for Windows is used for data collection and are expressed
s means, with SD of the mean calculated when appropriate.
orrelations were sought using Pearson’s and Spearman’s
orrelation coefﬁcient and multivariate analysis was per-
ormed by using a stepwise regression model. p < 0.05 was
egarded as signiﬁcance.
